Sonoma Pharmaceuticals, Inc.
- SNOA
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Hypochlorous Acid Therapeutics
- Wound/Skin Care
$1.12
Quote Oct 19, 2026, 08:00 PM UTC
−12.50%over the last month
Max drawdown −13.5%From 1-month high −13.5%3 months −6.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions.
Where the money comes from
Q1 2027 revenue $6.4M
- Human Care$6.0M93.1%
- Animal Care$439,0006.9%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
10
Founded
1999
Market value
$5.4M
Quote Oct 19
Floor
$1.11
1.0% below price
Resistance
$1.18
5.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SNOAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free